These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4451889)

  • 1. Influence of starvation on absorption, distribution, and action of barbital in mice and rats.
    Brodeur J; Lalonde S; Leroux J
    Can J Physiol Pharmacol; 1974 Dec; 52(6):1192-200. PubMed ID: 4451889
    [No Abstract]   [Full Text] [Related]  

  • 2. Stereospecificity of anesthetic activity, distribution, inactivation and protein binding of the optical antipodes of two N-methylated barbiturates.
    Büch H; Knabe J; Buzello W; Rummel W
    J Pharmacol Exp Ther; 1970 Dec; 175(3):709-16. PubMed ID: 5496138
    [No Abstract]   [Full Text] [Related]  

  • 3. Anesthetic potency and acute toxicity of optically active disubstituted barbituric acids.
    Christensen HD; Lee IS
    Toxicol Appl Pharmacol; 1973 Dec; 26(4):495-503. PubMed ID: 4771600
    [No Abstract]   [Full Text] [Related]  

  • 4. Similar development of tolerance to barbital-induced inhibition of avoidance behavior and loss of righting reflex in rats.
    Richter JA; Harris PS; Hanford PV
    Pharmacol Biochem Behav; 1982 Mar; 16(3):467-71. PubMed ID: 7079283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some effects of ethanol on the toxicity and distribution of barbiturates in rats.
    Coldwell BB; Wiberg GS; Trenholm HL
    Can J Physiol Pharmacol; 1970 Apr; 48(4):254-64. PubMed ID: 5458955
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction time measurement of barbital tolerance in mice given recurrent subhypnotic dosage of barbital.
    Risher DL; Baccus AL; Townsend SW; Proctor CD
    J Natl Med Assoc; 1982 Dec; 74(12):1183-7. PubMed ID: 7154102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of tricyclic antidepressants and barbiturates in barbiturate-tolerant and nontolerant rats.
    Liu SJ; Huang CL; Waters IW
    J Pharmacol Exp Ther; 1975 Aug; 194(2):285-95. PubMed ID: 1151759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barbital-induced cross-tolerance to barbiturates by the intracisternal route of administration.
    Stolman S; Loh HH
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):309-16. PubMed ID: 1197916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possibilities of using a new binding substance in barbital and sodium barbital tablets].
    Zakrzhevskaia TN; Kuiantseva AM; Shatalova NV
    Farmatsiia; 1978; 27(2):19-23. PubMed ID: 640028
    [No Abstract]   [Full Text] [Related]  

  • 10. Potencies of barbiturates in mice selectively bred for resistance or susceptibility to nitrous oxide anesthesia.
    Koblin DD; Lurz FW; O'Connor B; Nelson NT; Eger EI; Bainton CR
    Anesth Analg; 1984 Jan; 63(1):35-9. PubMed ID: 6691562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural interactions between imidazoleacetic acid and gamma-hydroxybutyric acid in rats and mice.
    Benton D; Kyriacou CP; Rick JT; Taberner PV
    Eur J Pharmacol; 1974 Aug; 27(3):288-93. PubMed ID: 4425346
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in serotonin turnover and the brain sensitivity to barbiturates by disulfiram treatment in rats.
    Minegishi A; Fukumori R; Satoh T; Kitagawa H; Yanaura S
    Res Commun Chem Pathol Pharmacol; 1979 May; 24(2):273-87. PubMed ID: 461985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional distribution of barbital in the brain of mice during the development of tolerance and physical dependence.
    Lin SC; Sutherland VC
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):215-31. PubMed ID: 562525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain barbital levels and anesthesia as influenced by physostigmine and epinephrine.
    Mazel P; Bush MT
    Biochem Pharmacol; 1969 Mar; 18(3):579-86. PubMed ID: 5772588
    [No Abstract]   [Full Text] [Related]  

  • 15. Alterations of barbiturate action following 1,1-dichloroethylene, corticosterone, or acrolein.
    Jaeger RJ; Murphy SD
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):281-92. PubMed ID: 4766550
    [No Abstract]   [Full Text] [Related]  

  • 16. Disulfiram enhances pharmacological activity of barbital and impairs its urinary elimination.
    Sharkawi M; Cianflone D
    Science; 1978 Aug; 201(4355):543-4. PubMed ID: 663674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin antagonizes the effects of ethanol: effect of route of administration.
    Elmer GI; George FR
    NIDA Res Monogr; 1989; 95():502-3. PubMed ID: 2641043
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of experimental local inflammation on the action of barbiturates in rat.
    Prabhu VG; Rise NL; Oester YT
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):343-50. PubMed ID: 5015939
    [No Abstract]   [Full Text] [Related]  

  • 19. N,N'-diallylpentobarbital: antagonism of barbital in mice and rats.
    Yamamoto I; Tateoka Y; Watanabe K; Ho IK
    Life Sci; 1987 Apr; 40(14):1439-42. PubMed ID: 3561158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-tolerance to centrally injected barbiturates.
    Lyness WH; Brezenoff HE; Mycek MJ
    Eur J Pharmacol; 1979 Mar; 54(4):319-30. PubMed ID: 436931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.